MetaCap

Processa Pharmaceuticals (PCSA) vs 60 Degrees Pharmaceuticals (SXTP)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Processa Pharmaceuticals is the larger company by market cap ($4.0 million vs $3.9 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

PCSA versus SXTP key metrics
MetricPCSASXTP
Share price$1.42$1.10
Market cap$3.97M$3.87M
1-day change-5.96%-0.90%
EPS (TTM)$-4.33$-5.34
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$11.08$8.62
52-week low$1.41$0.84
Distance from 52-week high-87.18%-87.24%
Average volume228.15K129.39K
Shares outstanding2.79M3.52M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

PCSA vs SXTP FAQ

Which is bigger, Processa Pharmaceuticals or 60 Degrees Pharmaceuticals?

Processa Pharmaceuticals (PCSA) is larger, with a market capitalization of $3.97M compared with $3.87M for 60 Degrees Pharmaceuticals (SXTP).

Are Processa Pharmaceuticals and 60 Degrees Pharmaceuticals in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons